毛周角化病的临床诊疗与研究进展
Clinical Diagnosis, Treatment and Research Progress of Keratosis Pilaris
摘要: 毛周角化病(KP)也被称作毛发苔藓,是较为常见的一类过度角化性皮肤病。它主要表现为毛囊口处的小丘疹且伴随程度不一的毛囊周围红斑,我们针对这类常见又常让人困扰的疾病,从发病机制、症状表现以及治疗手段等方面开展了最新的梳理总结,研究发现毛周角化病归属于毛囊角化性疾病谱系,其中单纯型毛周角化病最为多见,其他变异型与罕见亚型则有红色毛周角化病、面颈部毛囊性红斑黑变病以及萎缩性毛周角化病相关谱系,FLG基因与ABCA12基因发生遗传突变是引发该病的核心因素,毛周角化病或许和寻常型鱼鳞病联系紧密与特应性皮炎的关联则可能性偏低,毛周角化病需重点鉴别的病症有棘状苔藓病以及寻常性鱼鳞病等。日常皮肤护理手段有做好皮肤保湿、避免长时间泡澡或淋浴,最好选用性质温和的香皂或清洁产品,外用角质剥脱剂属于首选治疗方案,后续可搭配外用维A酸类药物,若患者经局部治疗后效果不佳,还可以选择各类激光治疗与微晶磨皮术。
Abstract: Keratosis pilaris (KP), also known as lichen pilaris, is a relatively common type of hyperkeratotic skin disease. It is mainly characterized by small papules at the hair follicle orifices accompanied by varying degrees of perifollicular erythema. We have conducted the latest review and summary on this common and often troublesome disease in terms of pathogenesis, clinical manifestations, and treatment methods. The study found that keratosis pilaris belongs to the spectrum of follicular keratotic diseases, among which the simple type of keratosis pilaris is the most common. Other variants and rare subtypes include erythromelanosis follicularis faciei, atrophicans-related spectrum, and keratosis pilaris rubra. Genetic mutations in the FLG gene and the ABCA12 gene are the core factors causing this disease. Keratosis pilaris may be closely related to ichthyosis vulgaris, but its association with atopic dermatitis is less likely. The diseases that need to be mainly differentiated from keratosis pilaris include lichen spinulosus, pituitary tumor disease, and ichthyosis vulgaris. Daily skin care measures, such as maintaining skin moisture, avoiding long baths or showers, and preferably using mild soaps or cleaning products, are important. Topical keratolytics are the first-line treatment, which can be followed by topical retinoids. If the patient’s response to local treatment is poor, various laser treatments and microdermabrasion can also be considered.
文章引用:张家宁, 张子豪, 张再兴, 张晓冬. 毛周角化病的临床诊疗与研究进展[J]. 临床医学进展, 2026, 16(3): 1812-1821. https://doi.org/10.12677/acm.2026.163967

参考文献

[1] Mevorah, B., Marazzi, A. and Frenk, E. (1985) The Prevalence of Accentuated Palmoplantar Markings and Keratosis Pilaris in Atopic Dermatitis, Autosomal Dominant Ichthyosis and Control Dermatological Patients. British Journal of Dermatology, 112, 679-685. [Google Scholar] [CrossRef] [PubMed]
[2] Forman, L. (1954) Keratosis Pilaris. Bulletin de la Société Française de Dermatologie et de Syphiligraphie, 61, 192-194.
[3] Poskitt, L. and Wilkinson, J.D. (1994) Natural History of Keratosis Pilaris. British Journal of Dermatology, 130, 711-713. [Google Scholar] [CrossRef] [PubMed]
[4] Thomas, M. and Khopkar, U.S. (2012) Keratosis Pilaris Revisited: Is It More Than Just a Follicular Keratosis? International Journal of Trichology, 4, 255-258.
[5] Ueda, A. (2014) Treatment of Lichen Pilaris with a Q-Switched Nd:Yag Laser in Quasi Long-Pulsed Mode: A Case Report (A Secondary Publication). LASER THERAPY, 23, 211-220. [Google Scholar] [CrossRef] [PubMed]
[6] Pennycook, K.B. and McCready, T.A. (2023) Keratosis Pilaris. StatPearls Publishing.
[7] Wang, J.F. and Orlow, S.J. (2018) Keratosis Pilaris and Its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options. American Journal of Clinical Dermatology, 19, 733-757. [Google Scholar] [CrossRef] [PubMed]
[8] Kootiratrakarn, T., Kampirapap, K. and Chunhasewee, C. (2015) Epidermal Permeability Barrier in the Treatment of Keratosis Pilaris. Dermatology Research and Practice, 2015, 1-5. [Google Scholar] [CrossRef] [PubMed]
[9] Liakou, A.I., Esteves de Carvalho, A.V. and Nazarenko, L.P. (2014) Trias of Keratosis Pilaris, Ulerythema Ophryogenes and 18p Monosomy: Zouboulis Syndrome. The Journal of Dermatology, 41, 371-376. [Google Scholar] [CrossRef] [PubMed]
[10] Gruber, R., Sugarman, J.L., Crumrine, D., Hupe, M., Mauro, T.M., Mauldin, E.A., et al. (2015) Sebaceous Gland, Hair Shaft, and Epidermal Barrier Abnormalities in Keratosis Pilaris with and without Filaggrin Deficiency. The American Journal of Pathology, 185, 1012-1021. [Google Scholar] [CrossRef] [PubMed]
[11] Oranje, A.P., Van Osch, L.D. and Oosterwijk, J.C. (1994) Keratosis Pilaris Atrophicans. One Heterogeneous Disease or a Symptom in Different Clinical Entities? Archives of Dermatological Research, 130, 500-502.
[12] Barth, J.H., Wojnarowska, F. and Dawber, R.P.R. (1988) Is Keratosis Pilaris Another Androgen-Dependent Dermatosis? Clinical and Experimental Dermatology, 13, 240-241. [Google Scholar] [CrossRef] [PubMed]
[13] Brown, S.J., Relton, C.L., Liao, H., Zhao, Y., Sandilands, A., Wilson, I.J., et al. (2008) Filaggrin Null Mutations and Childhood Atopic Eczema: A Population-Based Case-Control Study. Journal of Allergy and Clinical Immunology, 121, 940-946.e3. [Google Scholar] [CrossRef] [PubMed]
[14] Salava, A., Salo, V. and Remitz, A. (2022) Keratosis Pilaris and Filaggrin Loss-of-Function Mutations in Patients with Atopic Dermatitis—Results of a Finnish Cross-Sectional Study. The Journal of Dermatology, 49, 928-932. [Google Scholar] [CrossRef] [PubMed]
[15] Barresi, C., Stremnitzer, C., Mlitz, V., Kezic, S., Kammeyer, A., Ghannadan, M., et al. (2011) Increased Sensitivity of Histidinemic Mice to UVB Radiation Suggests a Crucial Role of Endogenous Urocanic Acid in Photoprotection. Journal of Investigative Dermatology, 131, 188-194. [Google Scholar] [CrossRef] [PubMed]
[16] Kezic, S., O’Regan, G.M., Yau, N., Sandilands, A., Chen, H., Campbell, L.E., et al. (2011) Levels of Filaggrin Degradation Products Are Influenced by Both Filaggrin Genotype and Atopic Dermatitis Severity. Allergy, 66, 934-940. [Google Scholar] [CrossRef] [PubMed]
[17] Nakagawa, N., Sakai, S., Matsumoto, M., Yamada, K., Nagano, M., Yuki, T., et al. (2004) Relationship between NMF (Lactate and Potassium) Content and the Physical Properties of the Stratum Corneum in Healthy Subjects. Journal of Investigative Dermatology, 122, 755-763. [Google Scholar] [CrossRef] [PubMed]
[18] Rawlings, A.V. and Harding, C.R. (2004) Moisturization and Skin Barrier Function. Dermatologic Therapy, 17, 43-48. [Google Scholar] [CrossRef] [PubMed]
[19] Zouboulis, C.C., Schagen, S. and Alestas, T. (2008) The Sebocyte Culture: A Model to Study the Pathophysiology of the Sebaceous Gland in Sebostasis, Seborrhoea and Acne. Archives of Dermatological Research, 300, 397-413. [Google Scholar] [CrossRef] [PubMed]
[20] Barth, J.H., Ng, L.L., Wojnarowska, F. and Dawber, R.P. (1988) Acanthosis Nigricans, Insulin Resistance and Cutaneous Virilism. British Journal of Dermatology, 118, 613-619.
[21] Salava, A., Salo, V., Leppänen, J., Lauerma, A. and Remitz, A. (2022) Factors Associated with Severity of Atopic Dermatitis—A Finnish Cross-Sectional Study. Journal of the European Academy of Dermatology and Venereology, 36, 2130-2139. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, F., Yang, Y., Zheng, Y., Liang, Y. and Zeng, K. (2018) Mutation and Expression of aBCa12 in Keratosis Pilaris and Nevus Comedonicus. Molecular Medicine Reports, 18, 3153-3158. [Google Scholar] [CrossRef] [PubMed]
[23] Jimenez-Cauhe, J., Fernandez-Gonzalez, P., Ortega-Quijano, D., Fernandez-Nieto, D. and Saceda-Corralo, D. (2021) Keratosis Pilaris-Like Eruption Induced by Nilotinib. Italian Journal of Dermatology and Venereology, 156, 47-48. [Google Scholar] [CrossRef] [PubMed]
[24] Frioui, R., Rabhi, F., Gargouri, F., Jaber, K. and Dhaoui, A. (2021) Nilotinib-Induced Keratosis Pilaris Associated with Cicatricial Alopecia Resembling Frontal Fibrosing Alopecia. Dermatologic Therapy, 34, e14579. [Google Scholar] [CrossRef] [PubMed]
[25] Oro-Ayude, M., Feito, M., Quintana-Castanedo, L., Beato-Merino, M.J. and De Lucas, R. (2020) Keratosis Pilaris-Like Eruption Secondary to Nilotinib in a Child. Pediatric Dermatology, 37, 968-969. [Google Scholar] [CrossRef] [PubMed]
[26] Kowe, P.A., Wankhade, V.H., Malpani, S.S. and Singh, R.P. (2021) Nilotinib-Induced Generalized Keratosis Pilaris: Report of a Rare Case. Indian Journal of Pharmacology, 53, 330-331. [Google Scholar] [CrossRef] [PubMed]
[27] El Khoury, R., Tawil, M., Tomb, R. and Ghosn, M. (2017) Nilotinib-Induced Keratosis Pilaris Associated with Alopecia Areata and Eyebrow Thinning. International Journal of Trichology, 9, 87-89. [Google Scholar] [CrossRef] [PubMed]
[28] Rinderknecht, J.D., Goldinger, S.M., Rozati, S., Kamarashev, J., Kerl, K., French, L.E., et al. (2013) Rasopathic Skin Eruptions during Vemurafenib Therapy. PLOS ONE, 8, e58721. [Google Scholar] [CrossRef] [PubMed]
[29] Hwang, S. and Schwartz, R.A. (2008) Keratosis Pilaris: A Common Follicular Hyperkeratosis. Cutis, 82, 177-180.
[30] Panchaprateep, R., Tanus, A. and Tosti, A. (2015) Clinical, Dermoscopic, and Histopathologic Features of Body Hair Disorders. Journal of the American Academy of Dermatology, 72, 890-900. [Google Scholar] [CrossRef] [PubMed]
[31] Marqueling, A.L., Gilliam, A.E., Prendiville, J., Zvulunov, A., Antaya, R.J., Sugarman, J., et al. (2006) Keratosis Pilaris Rubra: A Common but Underrecognized Condition. Archives of Dermatological Research, 142, 1611-1616.
[32] Lateef, A. and Schwartz, R.A. (1999) Keratosis Pilaris. Cutis, 63, 205-207.
[33] Morton, C.M., Bhate, C., Janniger, C.K. and Schwartz, R.A. (2014) Ulerythema Ophryogenes: Updates and Insights. Cutis, 93, 83-87.
[34] Arnold, A.W. and Buechner, S.A. (2006) Keratosis Pilaris and Keratosis Pilaris Atrophicans Faciei. Journal der Deutschen Dermatologischen Gesellschaft, 4, 319-323. [Google Scholar] [CrossRef] [PubMed]
[35] Borkovic, S.P., Schwartz, R.A. and McNutt, N.S. (1984) Unilateral Erythromelanosis Follicularis Faciei et Colli. Cutis, 33, 163-170.
[36] Augustine, M. and Jayaseelan, E. (2008) Erythromelanosis Follicularis Faciei et Colli: Relationship with Keratosis Pilaris. Indian Journal of Dermatology, Venereology and Leprology, 74, 47-49.
[37] Rather, S., Yaseen, A. and Mukhija, M. (2016) Erythromelanosis Follicularis Faciei et Colli—A Cross-Sectional, Descriptive Study. Indian Journal of Dermatology, 61, 308-313. [Google Scholar] [CrossRef] [PubMed]
[38] Castela, E., Chiaverini, C., Boralevi, F., Hugues, R. and Lacour, J.P. (2012) Papular, Profuse, and Precocious Keratosis Pilaris. Pediatric Dermatology, 29, 285-288. [Google Scholar] [CrossRef] [PubMed]
[39] Brown, S.J., Relton, C.L., Liao, H., Zhao, Y., Sandilands, A., McLean, W.H.I., et al. (2009) Filaggrin Haploinsufficiency Is Highly Penetrant and Is Associated with Increased Severity of Eczema: Further Delineation of the Skin Phenotype in a Prospective Epidemiological Study of 792 School Children. British Journal of Dermatology, 161, 884-889. [Google Scholar] [CrossRef] [PubMed]
[40] Williams, H.C., Jburney, P.G., Hay, R.J., Archer, C.B., Shipley, M.J., Ahunter, J.J., et al. (1994) The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. British Journal of Dermatology, 131, 383-396. [Google Scholar] [CrossRef] [PubMed]
[41] Boza, J.C., Trindade, E.N., Peruzzo, J., Sachett, L., Rech, L. and Cestari, T.F. (2012) Skin Manifestations of Obesity: A Comparative Study. Journal of the European Academy of Dermatology and Venereology, 26, 1220-1223. [Google Scholar] [CrossRef] [PubMed]
[42] Güven, M., Anık, A., Ünüvar, T., İlgün Gürel, D. and Şendur, N. (2022) Cutaneous Manifestations of Obesity in Turkish Children: A Comparative Study. Pediatric Dermatology, 39, 513-519. [Google Scholar] [CrossRef] [PubMed]
[43] Pavlović, M.D., Milenković, T., Dinić, M., Mišović, M., Daković, D., Todorović, S., et al. (2007) The Prevalence of Cutaneous Manifestations in Young Patients with Type 1 Diabetes. Diabetes Care, 30, 1964-1967. [Google Scholar] [CrossRef] [PubMed]
[44] Piérard, G.E., Soyeur-Broux, M., Estrada, J.A., Piérard-Franchimont, C., Soyeur, D. and Verloes, A. (1990) Cutaneous Presentation of the Cardio-Facio-Cutaneous Syndrome. Journal of the American Academy of Dermatology, 22, 920-922. [Google Scholar] [CrossRef] [PubMed]
[45] Bilgili, S.G., Akdeniz, N., Karadag, A.S., Akbayram, S., et al. (2011) Mucocutaneous Disorders in Children with Down Syndrome: Casecontrolled Study. Journal of Genetic Counseling, 22, 385-392.
[46] Daneshpazhooh, M., Mohammad-Javad Nazemi, T., Bigdeloo, L. and Yoosefi, M. (2007) Mucocutaneous Findings in 100 Children with down Syndrome. Pediatric Dermatology, 24, 317-320. [Google Scholar] [CrossRef] [PubMed]
[47] Ritter, A.M. and Wine Lee, L. (2022) Keratosis Pilaris in Collagen Type VI-Related Disorders. Pediatric Dermatology, 39, 133-134. [Google Scholar] [CrossRef] [PubMed]
[48] Fernández‐Canga, P., Vázquez‐Osorio, I., Álvarez‐Cuesta, C.C. and Rodríguez‐Díaz, E. (2019) Noonan-Syndrom mit multiplen lentigines und ausgeprägter Keratosis pilaris. Journal der Deutschen Dermatologischen Gesellschaft, 17, 748-751. [Google Scholar] [CrossRef] [PubMed]
[49] Purnak, S., Topçu, V., Çavdarlı, B., Kadan, E. and Yalçın, B. (2018) Widespread Keratosis Pilaris in a Patient with Noonan Syndrome with Multiple Lentigines. International Journal of Dermatology, 57, e140-e141. [Google Scholar] [CrossRef] [PubMed]
[50] Matriwong, P., Langkungamvong, N. and Asawanonda, P. (2019) Intense Pulsed-Light Therapy Significantly Improves Keratosis Pilaris: A Randomized, Double-Blind, Sham Irradiation-Controlled Trial. The Journal of Clinical and Aesthetic Dermatology, 12, 53-57.
[51] Bessis, D., Miquel, J., Bourrat, E., Chiaverini, C., Morice‐Picard, F., Abadie, C., et al. (2019) Dermatological Manifestations in Noonan Syndrome: A Prospective Multicentric Study of 129 Patients Positive for Mutation. British Journal of Dermatology, 180, 1438-1448. [Google Scholar] [CrossRef] [PubMed]
[52] Friedman, S.J. (1990) Lichen Spinulosus. Clinicopathologic Review of 35 Cases. Journal of the American Academy of Dermatology, 22, 261-264. [Google Scholar] [CrossRef
[53] Alfadley, A., Al Hawsawi, K. and Al Aboud, K. (2003) Ichthyosis Follicularis: A Case Report and Review of the Literature. Pediatric Dermatology, 20, 48-51. [Google Scholar] [CrossRef] [PubMed]
[54] Youssefian, L., Naji, M., Park, J.S., Rajabi, F., Abdollahimajd, F., Mahmoudi, H., et al. (2022) Ichthyosis Follicularis Syndromes in Patients with Mutations in GJB2. Clinical and Experimental Dermatology, 47, 1561-1566. [Google Scholar] [CrossRef] [PubMed]
[55] Fong, K., Takeichi, T., Liu, L., Pramanik, R., Lee, J., Akiyama, M., et al. (2015) Ichthyosis Follicularis, Atrichia, and Photophobia Syndrome Associated with a New Mutation in MBTPS2. Clinical and Experimental Dermatology, 40, 529-532. [Google Scholar] [CrossRef] [PubMed]
[56] Di Stefani, A., Orlandi, A., Chimenti, S. and Bianchi, L. (2007) Phrynoderma: A Cutaneous Sign of an Inadequate Diet. Canadian Medical Association Journal, 177, 855-856. [Google Scholar] [CrossRef] [PubMed]
[57] Young, M.C., Jorizzo, J.L., Sanchez, R.L., Hebert, A.A., Thomas, D.R. and King, C.A. (1985) Trichostasis Spinulosa. International Journal of Dermatology, 24, 575-580. [Google Scholar] [CrossRef] [PubMed]
[58] Wang, D., Chong, V.C., Chong, W. and Oon, H.H. (2018) A Review on Pityriasis Rubra Pilaris. American Journal of Clinical Dermatology, 19, 377-390. [Google Scholar] [CrossRef] [PubMed]
[59] Suryawanshi, H., Dhobley, A., Sharma, A. and Kumar, P. (2017) Darier Disease: A Rare Genodermatosis. Journal of Oral and Maxillofacial Pathology, 21, 321-321. [Google Scholar] [CrossRef] [PubMed]
[60] Forouzandeh, M., Stratman, S. and Yosipovitch, G. (2020) The Treatment of Kyrle’s Disease: A Systematic Review. Journal of the European Academy of Dermatology and Venereology, 34, 1457-1463. [Google Scholar] [CrossRef] [PubMed]
[61] Zegarska, B., Kallas, D., Schwartz, R.A., Czajkowski, R., et al. (2010) Graham-Little Syndrome. Acta Dermatovenerol APA, 19, 39-42.
[62] Garwood, J.D. (1978) Keratosis Pilaris. American Family Physician, 17, 151-152.
[63] Suástegui-Rodríguez, I., Camacho-Rosas, L.H., Peralta-Pedrero, M.L., Cruz, F.J. and Morales-Sánchez, M.A. (2022) Keratosis Pilaris Treatment: Evidence from Intervention Studies. Skinmed, 20, 258-271.
[64] Novick, N.L. (1984) Practical Management of Widespread, Atypical Keratosis Pilaris. Journal of the American Academy of Dermatology, 11, 305-306. [Google Scholar] [CrossRef] [PubMed]
[65] Weber, T.M., Kowcz, A. and Rizer, R. (2004) Evaluation of a Sodium Lactate and Urea Crème to Ameliorate Keratosis Pilaris. Journal of the American Academy of Dermatology, 50, 47. [Google Scholar] [CrossRef
[66] Eckburg, A., Kazemi, T. and Maguiness, S. (2022) Keratosis Pilaris Rubra Successfully Treated with Topical Sirolimus: Report of a Case and Review of the Literature. Pediatric Dermatology, 39, 429-431. [Google Scholar] [CrossRef] [PubMed]
[67] Bogle, M.A., Ali, A. and Bartel, H. (2004) Tazarotene 0.05% Cream for the Treatment of Keratosis Pilaris. Journal of the American Academy of Dermatology, 50, 39. [Google Scholar] [CrossRef
[68] Gerbig, A.W. (2002) Treating Keratosis Pilaris. Journal of the American Academy of Dermatology, 47, 457. [Google Scholar] [CrossRef] [PubMed]
[69] Park, J., Kim, B.J., Kim, M.N. and Lee, C.K. (2011) A Pilot Study of Q-Switched 1064-nm Nd: YAG Laser Treatment in the Keratosis Pilaris. Annals of Dermatology, 23, Article 293. [Google Scholar] [CrossRef] [PubMed]
[70] Kim, S. (2011) Treatment of Pigmented Keratosis Pilaris in Asian Patients with a Novel Q-Switched Nd: YAG Laser. Journal of Cosmetic and Laser Therapy, 13, 120-122. [Google Scholar] [CrossRef] [PubMed]
[71] Saelim, P., Pongprutthipan, M., Pootongkam, S., Jariyasethavong, V. and Asawanonda, P. (2013) Long-Pulsed 1064-nm Nd:YAG Laser Significantly Improves Keratosis Pilaris: A Randomized, Evaluator-Blind Study. Journal of Dermatological Treatment, 24, 318-322. [Google Scholar] [CrossRef] [PubMed]
[72] Maitriwong, P., Tangkijngamvong, N. and Asawanonda, P. (2020) Innovative 1064-nm Nd:YAG Laser Significantly Improves Keratosis Pilaris, a Randomized, Double-Blind, Sham-Irradiation-Controlled Trial. Lasers in Surgery and Medicine, 52, 509-514. [Google Scholar] [CrossRef] [PubMed]
[73] Bayazit, S., Aşkın, Ö. and Kutlubay, Z. (2022) Comparative Study of the Efficacy of Fractional Er:YAG 2940 nm Laser and Q-Switched Nd:YAG 1064 nm Laser in Keratosis Pilaris. Journal of Cosmetic Dermatology, 21, 3809-3813. [Google Scholar] [CrossRef] [PubMed]
[74] Vachiramon, V., Anusaksathien, P., Kanokrungsee, S. and Chanprapaph, K. (2016) Fractional Carbon Dioxide Laser for Keratosis Pilaris: A Single-Blind, Randomized, Comparative Study. BioMed Research International, 2016, 1-6. [Google Scholar] [CrossRef] [PubMed]
[75] Ismail, S. and Omar, S.S. (2020) Clinical and Dermoscopic Evaluation of Fractional Carbon Dioxide Laser in Management of Keratosis Pilaris in Egyptian Type Skin. Journal of Cosmetic Dermatology, 19, 1110-1120. [Google Scholar] [CrossRef] [PubMed]
[76] Lee, S.J., Choi, M.J., Zheng, Z., Chung, W.S., Kim, Y.K. and Cho, S.B. (2013) Combination of 595-nm Pulsed Dye Laser, Long-Pulsed 755-nm Alexandrite Laser, and Microdermabrasion Treatment for Keratosis Pilaris: Retrospective Analysis of 26 Korean Patients. Journal of Cosmetic and Laser Therapy, 15, 150-154. [Google Scholar] [CrossRef] [PubMed]
[77] Li, M., Bai, Y., Duan, Z., Yuan, R., Liu, X., Liu, Y., et al. (2022) Efficacy and Safety of Long-Pulsed 755-nm Alexandrite Laser for Keratosis Pilaris: A Split-Body Randomized Clinical Trial. Dermatology and Therapy, 12, 1897-1906. [Google Scholar] [CrossRef] [PubMed]